ВАЖНО! Правила приравнивания журналов, входящих в международные базы данных к журналам перечня ВАК.
Ответ на официальный запрос в ВАК журнала Кардиология.

Preview

Kardiologiia

Advanced search

Mitral valve replacement and implantation of an extracardial mesh frame in patients with severe heart failure: results of a clinical study and a description of a clinical case 18 years after surgery

https://doi.org/10.18087/cardio.2021.9.n1769

Abstract

Aim    Dilated cardiomyopathy (DCMP) is a major cause for severe heart failure. Development of a combination (drug and surgery) treatment of this disease is relevant. This prospective observational study was aimed at evaluating short- and long-term results of extracardiac mesh implantation in DCMP patients with heart failure resistant to the optimum drug therapy.
Material and methods    The extracardiac mesh ACOR-1 was implanted in 15 patients with DCMP. All meshes were produced individually for each patient and made of Gelweave (great Britain) vascular graft strips. The mesh size corresponded to the heart diastolic size, which was measured after achieving a maximum possible clinical improvement for the patient. Long-term results were followed for up to 4 years. Mean age of patients was 43.1±10.8 years (from 28 to 62 years). One patient was followed up for 18 years. Data of that patient were presented as a clinical case report.
Results    From October, 2003 through October, 2007, 15 DCMP patients received mesh implants. Cases of in-hospital death were absent. In 3 mos. after the surgery, left ventricular volumes decreased (end-diastolic volume decreased from 251.7±80.7 to 229.0±61.3 ml; end-systolic volume decreased from 182.3±73.6 to 167.7±46.2 ml), and the left ventricular pump function improved (ejection fraction increased from 25.2±6.0 to 27.1±5.1 %; cardiac index increased from 2.0±0.5 to 2.4±0.7 ml /min /m2). The functional state of patients improved by one NYHA class, from 3.7±0.3 to 2.8±0.6. In some cases, the left ventricular size and the systolic function completely normalized. There were no episodes of circulatory decompensation in the long term after surgery. Actuarial survival for the observation period was 100%.
Conclusion    Implantation of extracardiac mesh prevented progression of heart dilatation and, in combination with drug therapy, it may represent an effective method for treatment of DCMP.

About the Authors

Yu. N. Belenkov
Sechenov Moscow State Medical University, Moscow, Russia
Russian Federation

Director of the Ostroumov Clinic of Hospital Therapy



A. V. Koroteev
Sechenov Moscow State Medical University, Moscow, Russia
Russian Federation


V. Yu. Mareev
Medical Research and Educational Center of the M. V. Lomonosov Moscow State University, Moscow, Russia Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia
Russian Federation

Chief Researcher Medical Research and Education Center of Moscow State University M.V. Lomonosova, Moscow, Russia



References

1. Fomin I.V. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Journal of Cardiology. 2016;8:7–13. DOI: 10.15829/1560-4071-2016-8-7-13

2. Belenkov Yu.N., Mareev V.Yu., Ageev F.T. Epidemiological studies on heart failure: a background. Russian Heart Failure Journal. 2002;3(2):57–8.

3. Mareev V.Yu., Belenkov Yu.N. Prospects in treatment of chronic heart failure. Russian Heart Failure Journal. 2002;3(3):109–14.

4. Koroteev A.V., Belianko I.E., Dolotov V.K., Nechaev I.A., Ternovska

5. ya E.A., Kulagina T.Yu. et al. Implantation of extracardiac netlike frame: a new surgical technology in the treatment of heart failire. International Journal of Interventional Cardioangiology. 2008;14:60–1.

6. Gautier S.V., Itkin G.P., Shemakin S.Yu., Saitgareev R.Sh., PoptsovV.N., Zakharevich V.M. et al. The first experience in clinical application

7. of domestic circulatory support devicde on basis of implantable axi

8. al pump for two stage heart transplantation. Russian Journal of Transplantology and Artificial Organs. 2015;15(3):92–101. DOI: 10.15825/1995-1191-2013-3-92-101

9. Koroteev A.V. Method for surgical therapy of dilatation cardiomyopathy. Patent RU 2190966 C1. Application from 20.09.2001. Av. at: https://yandex.ru/patents/doc/RU2190966C1_20021020.

10. Sychyov A.V., Gerasimova V.V., Mareev V.Yu., Korobkova I.Z., Koroteev A.V., Ovchinnikov A.G. et al. Prosthesis of mitral valve and implantation of gauze framework in patients with severe HF. Russian Heart Failure Journal. 2005;6(5):209–12.

11. Konertz W, Dushe S, Hotz H, Braun JP, Spiess C, Endzweiler C etal. Safety and feasibility of a cardiac support device. Journal of Cardiac Surgery. 2001;16(2):113–7. DOI: 10.1111/j.1540-8191.2001.tb00495.x

12. Konertz WF, Shapland JE, Hotz H, Dushe S, Braun JP, Stantke K et al. Passive containment and reverse remodeling by a novel textile cardiac support device. Circulation. 2001;104(12 Suppl 1):I270-275. DOI: 10.1161/hc37t1.094525

13. Konertz W. Berlin experiences with the ‘CorCap’. Hearts have become smaller, pump function is improved. MMW Fortschritte der Medizin. 2004;146(49):5. PMID: 15646706

14. Sabbah HN. Global Leſt Ventricular Remodeling with the Acorn Cardiac Support Device: Hemodynamic and Angiographic Findings in Dogs with Heart Failure. Heart Failure Reviews. 2005;10(2):109–15. DOI: 10.1007/s10741-005-4638-9

15. Konstantinov B.A., Korotkov A.V., Belianko I.E., Sandrikov V.A., Dolotov V.K., Ternovskaia E.A. et al. Surgical treatment of dilated cardiomyopathy. Pirogov Russian Journal of Surgery. 2006; 9:4–10.

16. Acker MA, Bolling S, Shemin R, Kirklin J, Oh JK, Mann DL et al. Mitral valve surgery in heart failure: Insights from the Acorn Clinical Trial. The Journal of Thoracic and Cardiovascular Surgery. 2006;132(3):568–77. DOI: 10.1016/j.jtcvs.2006.02.062

17. Varela CE, Fan Y, Roche ET. Optimizing Epicardial Restraint and Reinforcement Following Myocardial Infarction: Moving Towards Localized, Biomimetic, and Multitherapeutic Options. Biomimetics. 2019;4(1):7. DOI: 10.3390/biomimetics4010007

18. Hendriks T, Schurer RAJ, Al Ali L, van den Heuvel AFM, van der HarstP. Leſt ventricular restoration devices post myocardial infarction. Heart Failure Reviews. 2018;23(6):871–83. DOI: 10.1007/s10741-018-9711-2

19. Kapnisi M, Mansfield C, Marijon C, Guex AG, Perbellini F, BardiI et al. Auxetic Cardiac Patches with Tunable Mechanical and Conductive Properties toward Treating Myocardial Infarction. Advanced Functional Materials. 2018;28(21):1800618. DOI: 10.1002/adfm.201800618

20. Park J, Choi S, Janardhan AH, Lee S-Y, Raut S, Soares J et al. Electromechanical cardioplasty using a wrapped elasto-conductive epicardial mesh. Science Translational Medicine. 2016;8(344):344ra86. DOI: 10.1126/scitranslmed.aad8568

21. Payne CJ, Wamala I, Bautista-Salinas D, Saeed M, Van Story D, Thalhofer T et al. Soſt robotic ventricular assist device with septal bracing for therapy of heart failure. Science Robotics. 2017;2(12):eaan6736. DOI: 10.1126/scirobotics.aan6736


Review

For citations:


Belenkov Yu.N., Koroteev A.V., Mareev V.Yu. Mitral valve replacement and implantation of an extracardial mesh frame in patients with severe heart failure: results of a clinical study and a description of a clinical case 18 years after surgery. Kardiologiia. 2021;61(9):4-10. (In Russ.) https://doi.org/10.18087/cardio.2021.9.n1769

Views: 1251


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0022-9040 (Print)
ISSN 2412-5660 (Online)